Evidence map›Paper›PMID 35881468›Full record

ArticleJournal of industrial microbiology & biotechnology2022

Expanding the genetic engineering toolbox for the metabolically flexible acetogen Eubacterium limosum.

Patrick A Sanford, Benjamin M Woolston

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. The human gut microbeApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Tungsten is utilized for lactate consumption and SCFA production by a dominant human gut microbeProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patrick A SanfordDepartment of Chemical Engineering, Northeastern University, 360 Huntington Avenue, 223 Cullinane, Boston, MA 02115, USA.
Benjamin M WoolstonDepartment of Chemical Engineering, Northeastern University, 360 Huntington Avenue, 223 Cullinane, Boston, MA 02115, USA.ORCID 0000-0002-6570-2236

Funding

Advanced Research Projects Agency - Energy #DE-AR0001511Department of EnergyNortheastern University
6 · The paper itself

Abstract

Acetogenic bacteria are an increasingly popular choice for producing fuels and chemicals from single carbon (C1) substrates. Eubacterium limosum is a promising acetogen with several native advantages, including the ability to catabolize a wide repertoire of C1 feedstocks and the ability to grow well on agar plates. However, despite its promise as a strain for synthetic biology and metabolic engineering, there are insufficient engineering tools and molecular biology knowledge to leverage its native strengths for these applications. To capitalize on the natural advantages of this organism, here we extended its limited engineering toolbox. We evaluated the copy number of three common plasmid origins of replication and devised a method of controlling copy number and heterologous gene expression level by modulating antibiotic concentration. We further quantitatively assessed the strength and regulatory tightness of a panel of promoters, developing a series of well-characterized vectors for gene expression at varying levels. In addition, we developed a black/white colorimetric genetic reporter assay and leveraged the high oxygen tolerance of E. limosum to develop a simple and rapid transformation protocol that enables benchtop transformation. Finally, we developed two new antibiotic selection markers-doubling the number available for this organism. These developments will enable enhanced metabolic engineering and synthetic biology work with E. limosum.

Indexed as

Genetic EngineeringMetabolic EngineeringAgarAnti-Bacterial AgentsCarbonEubacteriumOxygenAgarAnti-Bacterial AgentsCarbonOxygenC1 fermentationnon-modelsynthetic biology

Identifiers

PMID35881468
PMCPMC9559302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.